About the Journal
We are excited to announce that as of January 2025, European Heart Journal – Cardiovascular Pharmacotherapy is now fully Open Access. By making our research freely available to all, we aim to foster collaboration, accelerate scientific progress, and ensure that groundbreaking discoveries reach a broader audience. For more information please visit the FAQ page.
The European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP) is an official, international, peer-reviewed journal of the European Society of Cardiology (ESC) and the ESC Working Group on Cardiovascular Pharmacotherapy, with a specific focus on clinical cardiovascular pharmacology. It publishes original articles concerning clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews. The Journal aims to improve the pharmacological treatment of patients with cardiovascular disease through interpreting and integrating new scientific developments within this area.
While the focus is on clinical topics, basic research articles from fields such as physiology and molecular biology which contribute to an understanding of cardiovascular drug therapy are also considered, such as articles relevant to new drug development and evaluation, physiological and pharmacological bases of drug action, metabolism, drug interactions and side effects.
Issues published per year: 8
Articles available: online only
Access: open access from January 2025
| Metric | Current EHJ-CVP Score | Current EHJ-CVP Rank |
|---|---|---|
| Total citations in year (2023)1 | 1,629 | - |
| Journal Citation Indicator (JCI)1 | 1.69 |
29 / 222 in Cardiac & Cardiovascular Systems 20 / 354 in Pharmacology & Pharmacy |
| Immediacy Index1 | 1.4 | - |
| Journal Impact Factor1 | 5.4 |
36 / 222 in Cardiac & Cardiovascular Systems 34 / 354 in Pharmacology & Pharmacy |
| 5-year Impact Factor1 | 5.1 | - |
| Eigenfactor1 | 0.00337 | - |
| Scopus CiteScore2 | 10.1 |
43 / 387 in Cardiology and Cardiovascular Medicine 18 / 272 in Pharmacology (medical) |
| Source Normalized Impact per Paper (SNIP)2 | 1.260 | - |
Last updated: October 2024; Sources: (1) 2023 Journal Citation Reports™ (Clarivate, 2024), (2) CiteScore™ 2023 (Scopus, 2024)
